摘要 |
<p>The present invention is in the fields of medicine, pharmaceuticals, nutraceuticals, endocrinology and cardiology. The invention provides compositions comprising a statin, an inhibitor of the angiotensin converting enzyme, an antiplatelet compound and an anti- hyperglycemic compound for use in the treatment and/or prevention of cardiometabolic risk factors of Metabolic Syndrome and treatment and/or prevention of Metabolic Syndrome. The present invention provides for the use of such compositions in the manufacture of products for treatment and/or prevention of Metabolic Syndrome. The biguanide metformin of the composition could be present in extended release form allowing its use together with the other drugs in a single dosage form at low dose. This combination of drugs in a single daily dosage greatly improves compliance and adherence to treatment which is a critical factor for treating patients with Metabolic Syndrome.</p> |
申请人 |
NUCITEC S.A. DE C.V.;ROSADO, JORGE, L.;GARCIA PADILLA, SANDRA;DUARTE-VAZQUEZ, MIGUEL, ANGEL |
发明人 |
ROSADO, JORGE, L.;GARCIA PADILLA, SANDRA;DUARTE-VAZQUEZ, MIGUEL, ANGEL |